Literature DB >> 9694197

GDNF protects the cochlea against noise damage.

E M Keithley1, C L Ma, A F Ryan, J C Louis, E Magal.   

Abstract

Glial-derived neurotrophic factor (GDNF) was tested for its ability to prevent hearing and sensory cell loss in guinea pigs exposed to acoustic trauma. Hearing was measured prior to any treatment. Animals were exposed to damaging levels of noise either before or after local application of GDNF to one ear. Four weeks later, hearing and sensory cell loss was greater in the control ear than in the ear receiving GDNF before acoustic trauma or 2 h after trauma, but not 4 or 6 h after trauma. The results indicate that GDNF treatment in vivo can prevent cochlear sensory cell damage and hearing loss if present during or shortly after acoustic trauma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694197     DOI: 10.1097/00001756-199807130-00007

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  Immunocytochemical and morphological evidence for intracellular self-repair as an important contributor to mammalian hair cell recovery.

Authors:  J L Zheng; G Keller; W Q Gao
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

3.  Current aspects of hearing loss from occupational and leisure noise.

Authors:  S Plontke; H-P Zenner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

Review 4.  Pharmacological agents used for treatment and prevention in noise-induced hearing loss.

Authors:  Muhammed Sedat Sakat; Korhan Kilic; Sami Bercin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

Review 5.  Local inner-ear drug delivery and pharmacokinetics.

Authors:  Alec N Salt; Stefan K R Plontke
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

6.  Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation.

Authors:  U Pirvola; L Xing-Qun; J Virkkala; M Saarma; C Murakata; A M Camoratto; K M Walton; J Ylikoski
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

7.  Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.

Authors:  Hartmut Hahn; Bernd Kammerer; Andre DiMauro; Alec N Salt; Stefan K Plontke
Journal:  Hear Res       Date:  2006-01-25       Impact factor: 3.208

Review 8.  Gene therapy in the inner ear using adenovirus vectors.

Authors:  Jacob Husseman; Yehoash Raphael
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

9.  Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy.

Authors:  Bradley W Kesser; George T Hashisaki; Jeffrey R Holt
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

10.  Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.

Authors:  Omar Akil; Bas Blits; Lawrence R Lustig; Patricia A Leake
Journal:  Hum Gene Ther       Date:  2018-09-05       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.